PDS Biotechnology Corporation (PDSB) NASDAQ

0.89

+0.043(+5.05%)

Updated at December 04 04:00PM

Currency In USD

Valuation

Market Cap59.42M
Enterprise Value39.56M
P/E Ratio-1.16
PEG Ratio-0.11
Price/Sales Ratio715.81
Price/Book Ratio0
Enterprise/Revenue-441,518.18
Enterprise/EBITDA849.26

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-590.6
Operating Margin-138,222.19

Management Effectiveness

Return On Assets-0
Return On Equity-0.01

Income Statement

Revenue0
Revenue/Share0
Gross Profit-59,791
EBITDA-33.75M
Net Income-37.61M
Diluted EPS-1.03

Balance Sheet

Total Cash26.2M
Total Cash/Share558.97
Total Debt17.97M
Total Debt/Equity0.01
Current Ratio2.09
Book Value Per Share201.7

Price History

52-Week Change-59.84
52-Week High2.28
52-Week Low0.7
Moving Average 50 Days0.91
Moving Average 200 Days1.19

Statistics

Average Volume754,411
Shares Outstanding48.97M
% Held by Institutions12.24

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateMarch 18, 2019